At the heart of this evolution lies the growing prominence of biologics contract manufacturing, a strategic partnership that is reshaping the way pharmaceutical companies approach their production ...

Contract Pharmaceutical Manufacturing Market is expected to reach USD 450.07 Bn by 2032, exhibiting a CAGR of 9.9% from 2025 to 2032. BURLINGAME, CA, UNITED STATES, March 12, 2025 /EINPresswire ...

Siemens partners with Miko Pharma to develop cutting-edge pharmaceutical manufacturing facilities in Ghana. The agreement ...

Significant growth in demand for pharmaceuticals, such as GLP-1s, increased R&D spending for autonomous manufacturing, and the increased presence of contract manufacturers globally are among the key ...

Contract Pharmaceutical Manufacturing Market is expected to reach USD 450.07 Bn by 2032, exhibiting a CAGR of 9.9% from 2025 to 2032. BURLINGAME, CA, UNITED STATES ...

Furthermore, personalized medicine and the increase in pharmaceutical alliances are likely to propel the oral solid dose contract manufacturing market, offering more opportunities for industry ...

Contract Pharmaceutical Manufacturing Market Size, Share Contract Pharmaceutical Manufacturing Market is expected to reach USD 450.07 Bn by 2032, exhibiting a CAGR of 9.9% from 2025 to 2032. BURLINGAM ...

SINGAPORE] Boustead Singapore’s engineering and construction business unit, under its real estate solutions division Boustead ...

The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical contract ...